Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
He has connections (at least he says he does) outside the country.
His "connections" are probably from his webcam follies! ROTF!
Yes, you have framed the sentiment well .... just one adjustment with your use of "The King is Dead!" ..... Maybe, "Ding, Dong the _itch is DEAD! He was NEVER a King! He was NEVER a good person!
THANKS to all others who supplied the SEC with info, pertinent examples and leads and data points for them to follow .....
SAD this happened and Berman roamed this earth BUT JUSTICE/KARMA will prevail!
Good Luck to all ..... Stay SAFE! ..... Don't let this Berman ANIMAL turn you off to those that do have values and value life!
WOW! I just read the Indictment and supporting information. I wish I had 10 minutes alone with MF Berman! HATS OFF to the SEC and investigative entities. Berman is not only a business fraud BUT a sick, twisted individual that has shamelessly negatively impacted so many and dashed their hopes!
I truly hope he burns in Hell but will welcome knowing he rots in jail.
What a COWARD! SICK!
Anyone have a link to the criminal charges they can post here? THANKS!
SEC Charges Biotech Company and CEO with Fraud Concerning COVID-19 Blood Testing Device
Washington, D.C.--(Newsfile Corp. - December 18, 2020) - The Securities and Exchange Commission today announced charges against California-based biotechnology company Decision Diagnostics Corp. and its CEO, Keith Berman, with making false and misleading claims in numerous press releases that the company had developed a working, break-through technology that could accurately detect Covid-19 through a quick blood test. The SEC temporarily suspended trading in Decision Diagnostics' securities on April 23, 2020.
The SEC's complaint alleges that Decision Diagnostics and Berman seized upon the global pandemic through a series of press releases that falsely claimed Decision Diagnostics had developed a finger prick blood test that could detect Covid-19 in less than a minute. According to the complaint, from March 2020 to at least June 2020, Decision Diagnostics and Berman made false and misleading statements about the existence of Decision Diagnostics' Covid-19 device and progress towards FDA emergency use authorization. As alleged, at the time of these claims, Decision Diagnostics lacked a proven method for detecting the virus and had no physical testing device. Further, its advisors had warned that the testing kit they were trying to manufacture would not work as Decision Diagnostics had described. The complaint also alleges that the statements created the misleading impression that the test was soon to be introduced to the market and led to surges in the price and trading volume of Decision Diagnostics' stock.
"During this unprecedented time, when the need for truthful disclosures concerning Covid-19 tests is of vital importance, Decision Diagnostics and its CEO allegedly misled investors by claiming to have made a working test device when all they had was an idea that had not materialized into a product," said Stephanie Avakian, Director of the Division of Enforcement. "With the onset of the global pandemic, we quickly pivoted to identify potential areas of fraud. This case is another example of how the Commission will hold accountable those who exploit the pandemic to harm investors."
"In our complaint, we allege that Decision Diagnostics and Berman repeatedly made baseless representations to the investing public about market-moving events like progress in obtaining FDA approval and having breakthrough technology," said Anita B. Bandy, Associate Director of the Division of Enforcement. "Today's filing is a credit to the dedicated SEC staff, who continued to investigate after the trading suspension and quickly uncovered the alleged fraud."
The complaint, filed in the U.S. District Court for the Southern District of New York, charges Decision Diagnostics and Berman with violating antifraud provisions of the securities laws. The SEC is seeking a court order permanently enjoining both Decision Diagnostics and Berman from directly or indirectly violating those provisions and ordering them to pay civil penalties.
The Department of Justice's Market Integrity and Major Frauds Unit announced today that parallel criminal charges against Berman were also filed in the U.S. District Court for the District of Columbia.
The SEC's investigation, which is continuing, has been conducted by Ernesto Amparo, Carlisle Perkins and Lesley Atkins and supervised by Jeff Leasure and Ms. Bandy with invaluable assistance by Margaret A. Cain of the Office of Market Intelligence and Hane L. Kim of the Microcap Fraud Task Force, both members of the SEC's Coronavirus Steering Committee. The litigation will be handled by James Carlson, David Misler and supervised by Tom Bednar. The SEC appreciates the assistance of the Financial Industry Regulatory Authority.
Write your local CBS affiliate to pass on this link of the SEC filing .... maybe they will UPDATE the story and report on people who try to profit from the pandemic tragedy fraudulently ....
https://www.courtlistener.com/recap/gov.uscourts.nysd.550805/gov.uscourts.nysd.550805.1.0.pdf
38. Other examples of Berman’s false and misleading statements come from a mid-April 2020 interview with a New York affiliate of CBS that aired on television and then was posted on the station’s website on May 5, 2020. In the interview, Berman falsely and misleadingly described DECN’s Covid-19 testing kit as a “game changer” because “it works” and “it works fast.” At the time, DECN still had not manufactured a prototype or other device that could detect Covid-19 in a blood sample nor had DECN conducted any testing on Covid-19-infected blood samples to confirm that it “works.”
There is a "special" place for Berman and his co-conspirators in HELL!
Not enough! I want CRIMINAL CHARGES brought!
AGREED! The net should be cast to catch all the co-conspirators as well!
Berman and his cronies are the lowest form of POS that exist ..... like I said a LONG time ago ..... I hope he burns in HELL! Now I will settle for MF Berman and his cronies to ROT in jail!
I am sure the IRS will also take action at the appropriate time and many "threads" will be pulled by the authorities ..... what an early Christmas Gift ...... JUSTICE!
GO FINRA! GO SEC! GO FDA! GO IRS!
Berman solution to dilution .... Reverse Split!
Hope the SEC finishes 2020 on a high note with a denial of DECN's Suspension Appeal and starts 2021 off with a solid referral to at least one other regulatory agency for prosecution!
Where has the DECN hack been lately? Maybe legal put a muzzle on its trap?
GO SEC! GO FINRA! GO FDA! GO FBI! GO IRS! GO KARMIC JUSTICE!
Bumbling Berman gives new meaning to the acronym "PR" ...... Instead of "Press Release", it now connotes, "Price Reduction" .... ROTF!
Free Magic Carpet with every Swift Kit puchase in India! Guess Berman likes to rub his magic lamp?
GO FINRA! GO SEC! GO FDA! GO IRS! GO KARMIC FORCES!
Maybe DECN/Berman rather than having a PDF with GenUltimate Pre-TV Logs from Jan-Feb 2017 or a stale list of global "online" retailers on the Corporate Home Page, can list the foreign regulatory approvals providing a link when available or at least the approval date and number.....PROOF is always better than Prose EXCEPT when it involves Berman and his Merry Hacks ..... BTW, as of Oct 1, 2020, DECN is now 15,200,000 units behind on its statements/projections regarding Gen-Whatever for Covid AND of course, NO FDA EUA's!
GO SEC! GO FINRA! GO FDA! GO IRS! GO KARMA! GO INTERPOL!
DECN/PharmaTech NOT mentioned, as usual ....
https://indianexpress.com/article/explained/faster-cheaper-coronavirus-covid-19-tests-india-saliva-cough-sounds-6663609/
A previous DECN PR states that the "local" distributor would be responsible to get the necessary approvals from each country's regulatory entity (similar to the FDA) ..... does the Indian Government require such approval? IF YES, where is the Gen-Whatever approval information listed?
SHOW PROOF!
In the meantime, GO FINRA! GO SEC! GO IRS! GO FDA! GO KARMA!
BE CAREFUL YOU DON'T GET BIT!
Talk about DECN dated/stale material on the DECN website ....Home Page, no less ---- GenUltimate Test Strips Pre TV logs from 2017! Same goes for the Careers/Job Opportunities Page as well .... talk about a sh--show!
http://www.decisiondiagnostics.co/assets/documents/tv_campaign/GU_tvprelogs001.pdf
GO KARMIC JUSTICE and ALL Referring Regulatory/Investigative/Criminal Entities!
From the Division's Brief in Opposition:
D. FINRA’s Referral
On March 18, 2020, the Financial Industry Regulatory Authority (“FINRA”) referred Petitioner to the Division because it found the press releases issued between March 3, 2020 and March 18, 2020 to be suspicious and possible indications of an attempt to manipulate DECN’s
stock price. Perkins July 1 Decl. ¶ 19. FINRA routinely evaluates statements made in press releases, especially when combined with dramatic changes in trading volume and prices, to determine whether there is evidence that an individual or company has violated or may be
violating the federal securities laws. Perkins July 1 Decl. ¶ 18. FINRA’s referral of DECN was an additional factor justifying the Commission’s trading suspension to protect to the public.
Trump gives update on the nation's coronavirus testing strategy from the White House
Funny, DECN not even mentioned at the news conference ..... what a surprise!
How is that Gen-Whatever covid-19 test international launch that was to start Saturday doing?
Maybe Berman and his crew should flee the country? ROTF!
GO SEC! GO FINRA! GO FDA! GO IRS! STOP BUMBLING BERMAN!
Berman/Asbell scenario ....
http://securities.stanford.edu/filings-documents/1015/access96/1997623_r01c_961250.pdf
GO FINRA! GO SEC! GO FBI! GO IRS! GO FDA! GO criminal referrals!
ANOTHER DECN International Launch results? Gen-What-is-it-called-today?
Just like GenSure International Launch Sept 2017?
Just like the Perfect Partner?
Just like the $100M licensing agreement over 5 years?
Just like the GenViro 100,000 kits distributed for May 2020?
Just like the 15,000,000 unit GenViro forecast for Sept 2020?
DECN Yada, Yada, Yada!
GO SEC! GO IRS! GO FDA! GO FINRA! GO criminal referrals!
Here's another good quote, 'Those who do not learn history are doomed to repeat it.'
Below pink and now gray sheets lives the "DECN Sheeter" .... however Berman and Legion want to wrap it, it still stinks!
Have a good weekend and get away from this crap for a bit .... not worth your effort!
GO SEC! GO IRS! GO FINRA! GO FDA! Wonder where Bumble Berman will hide his ham sandwich tonight? ROTF!
Remember the "international launch" and "philanthropic coup" of GenSure on Sept 13, 2017? ANOTHER Berman/DECN "what ever happened" event ..... Check the side of a milk carton ....
https://www.accesswire.com/475228/Decision-Diagnostics-Announces-the-Launch-of-Its-Essential-New-GensureTM-Diabetic-Test-Strip-for-Developing-World-Markets
The deployment of GenSure!™ in the international and emerging markets (i.e. poorer countries) is not only business as usual for DECN, it's a tertiary revenue model and a socially responsible effort by the company to bring to light the diabetes epidemic in markets where there is very little product availability, lower education rates, and extraordinary death stats. The number of people with diabetes (those that are counted) has risen to 422 million in 2014. With the launch of our GenSure!™ product, the needs presented by the developing world are now being addressed, a business and philanthropic coup for the Company.
How's the $100M over 5 years licensing agreement, Paragon relationship, 15M GenViro Units in Sept, big box retail, GenFlavor of the Day, CVS, Kroger, and on and on and on .... NO WONDER the market did not react to the latest Berman/DECN Babble ..... The ONLY wonder here is how he has gotten away with this for so long and WHEN JUSTICE will be served ..... GO SEC! GO IRS! GO FINRA! GO FDA!
Asbell and Berman go back to the Access HealthNet days .... both named in the Class Action ..... a good read .... some items even sound similar of the not too distant DECN actions, relationships, happenings ....
Access HealthNet Class Action
GO SEC! GO FDA! GO FINRA! GO IRS! ..... Tic, Toc ....KNOCK, KNOCK!
I am confident this time, JUSTICE will be done!
Customer Service Video in India
Customer Service Video
Will today's DECN Press Release result in the same NON-Execution that has begotten the same fate as the 3 listed below ..... Statements made and NOT Kept!
DECN Press Release Sept 1, 2020 (in part) - "Pharma Tech Solutions, Inc., today announced that we have set September 26, 2020 as the launch date for our International version GenViro! Covid-19 Saliva Swift Kit."
DECN Press Release March 13, 2018 (in part) - "Mr. Berman continued, "DECN anticipates the GenChoice! introduction to International markets in June 2018 as a prelude to the eventual U.S. introduction. It is believed that GenChoice! will contribute $100 million in annual revenues per our pro forma financial forecast."
DECN Press Release Jan 1, 2018 (in part) - "2018 is expected to become a seminal year for DECN. It begins with the marketing of its launched GenSure!™ diabetic test strip, targeted for the patient population across the developing markets. … This intense activity begins January 15, 2018 with the global introduction of the GenSure!™ test strip."
DECN Press Release August 24, 2017 (in part) - "Decision Diagnostics Corp. (OTC PINK: DECN), a manufacturer, quality plan administrator, and exclusive worldwide sales, service, and regulatory process agent for GenUltimate!™ glucose test strips, the pre-market ready GenSure!™, to be launched in International markets on September 5, 2017 ..."
ANYONE EVER see GenChoice or GenSure ACTUALLY being sold internationally? SHOW PROOF!
BLAST FROM THE PAST ..... Sept 4, 2019 DECN Press Release .... Use your DECN Decoder Ring ... ALL TALK, NO EXECUTION AS USUAL!
DECN announces that they have solicited distribution agreements with distributors located in the following international countries:
Russian Federation (distributor chosen, distribution tentatively filled)
Post Brexit United Kingdom
Canada
India
Mexico, Central America and South America
South Africa
Discussions currently are currently focused on the company’s GenUltimate, GenChoice, GenPrecis and GenSure products. DECN will have more to say about its panacea GenUltimate TBG, which will be distributed internationally by a mega-distribution organization.
Discussions for GenUltimate TBG are nearly complete. A large Russian based distributor is deep into talks and is expected to execute a distribution contract shortly. In addition DECN has received written requests from Mexico, South Africa and India.
SOUND FAMILIAR?
Misleading? Fradulent? Deceptive? Ineptness? You decide ....
Is it possible the DECN "CREW" found out that the SEC investigation may have resulted in its referral to another regulatory or criminal prosecution agency?
It is GREAT to have a front seat and see Karma applied to Berman and crew!
KNOCK, KNOCK! Tic-Toc, Tic-Toc! For whom the bell tolls? Bumbling Berman!
GO IRS! GO SEC! GO FDA! GO FINRA! GO FTC! GO FBI/DOJ!
DECN/Berman's own words from the MARCH 16, 2020 Press Release:
1 - We are awaiting release of blood samples from previously infected people in Daegu, Korea, so that we can complete testing and make a ??nal report to the U.S. FDA so that we may secure our Emergency Waiver.
2 - In the meantime, all other requests made by the FDA will be met this week and next.
3 - Further, we will engage in the EU with administrators of the ISO
standard CE regulatory process this week.
TODAY:
NO EUA
NO EU CE approval
NO Product Delivery
ONE SEC SUSPENSION, so far!
GREAT RECORD OF DECN EXECUTION! TALK ABOUT PROOF!
GO FINRA! GO FDA! GO SEC! GO IRS!